It seems like every few days since Labor Day weekend we at Xconomy get invited to attend or cover an entrepreneurship competition. This is a good thing. It means there are more and more opportunities for innovators in New England to gain exposure to the business community and investors—as well as a chance to win … Continue reading “New England Biz Plan Competitions That Offer Cash and Connections to Entrepreneurs”
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs
San Diego-based Amylin Pharmaceuticals, the dark horse in the race to develop a new breed of weight-loss drugs, has struck a partnership with Japan-based Takeda Pharmaceuticals that could be worth more than $1 billion over time if the drug reaches certain goals in development and in the marketplace. The agreement calls for Amylin (NASDAQ: [[ticker:AMLN]]) … Continue reading “Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs”
MIT Elevator Pitch Contest Takes Startup Salesmanship to New Level
How does $300,000 an hour sound? Walking away with $5,000 for his 60-second pitch, the winner of Thursday night’s MIT $100K Elevator Pitch Contest (EPC), Rouzbeh Shahsavari, seemed pretty excited about it. His idea? Nanoengineered concrete that is twice as strong, cuts CO2 emissions in half, and is dramatically cheaper than typical concrete. The EPC … Continue reading “MIT Elevator Pitch Contest Takes Startup Salesmanship to New Level”
Pulmatrix Receives $30,200,000 Series B Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=175b2c27-b665-4448-90b0-3a77f64aeed8&Preview=1 Date 11/2/2009 Company Name Pulmatrix Mailing Address 99 Hayden Avenue Lexington, MA 02421 Company Description Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination. Website http://www.pulmatrix.com Transaction Type Venture Equity Transaction Amount $30,200,000 Transaction Round Series B Proceeds … Continue reading “Pulmatrix Receives $30,200,000 Series B Round”
NCR Corp Acquires Netkey for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=26838db9-bba9-4bd6-911a-eef297644254&Preview=1 Date 11/2/2009 Company Name Netkey Mailing Address 100 South Shore Drive East Haven, CT 06512 Company Description Netkey provides the industry-standard software platform for authoring, securing, monitoring and managing self-service applications delivered on kiosks, PC terminals and digital signs. Website http://www.netkey.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes … Continue reading “NCR Corp Acquires Netkey for Undisclosed Sum”
ASSIA Lands $10,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a8de8aa-c858-45d0-a45a-0f01d7818a72&Preview=1 Date 11/2/2009 Company Name ASSIA Mailing Address 303 Twin Dolphin Drive Redwood City, CA 94065 Company Description ASSIA, Inc (Adaptive Spectrum and Signal Alignment Incorporated) is the leading provider of high-performance software tools for the emerging high growth marketplace referred to as DSM (Dynamic Spectrum Management). ASSIA’s technology and software employ … Continue reading “ASSIA Lands $10,000,000 New Financing”
Intelleflex Corporation Receives $8,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b34c1ee-bc6e-4698-84dd-5189036055cc&Preview=1 Date 11/2/2009 Company Name Intelleflex Corporation Mailing Address 2465 Augustine Drive Santa Clara, CA 95054 Company Description Intelleflex is a Silicon Valley company focused on the next generation of radio frequency identification (RFID) products and applications. Website http://www.intelleflex.com Transaction Type Venture Equity Transaction Amount $8,000,000 Transaction Round Undisclosed Proceeds Purposes We’ll … Continue reading “Intelleflex Corporation Receives $8,000,000 New Financing Round”
Link_A_Media Devices Secures $18,000,000 Series C Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=08c99614-1d44-4bc6-b014-598bdc6c0781&Preview=1 Date 11/2/2009 Company Name Link_A_Media Devices Mailing Address 2550 Walsh Avenue Santa Clara, CA 95051 Company Description Link_A_Media Devices was founded in March 2004 with a vision to develop custom, integrated system solutions on a chip for linking digital information within and across different media devices. Link_A_Media Devices is a leader … Continue reading “Link_A_Media Devices Secures $18,000,000 Series C Funding”
Scoopler Obtains New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aac8284b-6769-40d9-bcd5-ef1f7d394a7d&Preview=1 Date 11/1/2009 Company Name Scoopler Mailing Address Undisclosed San Francisco, CA 94104 Company Description Scoopler is a real-time search engine. We aggregate and organize content being shared on the internet as it happens, like eye-witness reports of breaking news, photos and videos from big events, and links to the hottest memes … Continue reading “Scoopler Obtains New Financing”
Entrepreneur’s Forum: The Great, Good, Bad, and the Ugly
The San Diego Software Industry has organized a panel discussion with Mission Ventures partner Ted Alexander and Covario CEO Russ Mann about the factors that are most important to startups in this region. Networking and early registration begins at 5:30 p.m. More information and online registration is here:
CalIT2 Presents: 8th International Conference on Creating, Connecting and Collaborating through Computing
To evolve into a true knowledge society, it is critical that we transform computer-based human activities to engage users in the active process of creating, connecting, and collaborating together. The C5 conference is for researchers, technology developers, educators, and technology users who are concerned about developing and enabling human-oriented creation, connection, and collaboration processes. More … Continue reading “CalIT2 Presents: 8th International Conference on Creating, Connecting and Collaborating through Computing”
Vertex Hepatitis C Drug Passes Key Test With More Convenient, Twice-Daily Dose
Vertex Pharmaceuticals wants to make sure doctors walk away from this weekend’s big liver disease research meeting with two main ideas stuck in their heads. No. 1—The company’s experimental drug is showing that it can cure even the toughest-to-treat patients with hepatitis C. No. 2—it may work just as well in a twice-daily dose as … Continue reading “Vertex Hepatitis C Drug Passes Key Test With More Convenient, Twice-Daily Dose”
Qualcomm Town Hall Meeting with CEO Paul Jacobs
Join Qualcomm Chairman and CEO Paul Jacobs for a discussion about 3G mobile technologies. Jacobs will be joined by Qualcomm COO Len Lauer and Steve Mollenkopf, the executive vice president who also serves as president of Qualcomm CDMA Technologies (QCT), the world’s largest provier of wireless chipsets and software solutions. The agenda includes 3G multimode … Continue reading “Qualcomm Town Hall Meeting with CEO Paul Jacobs”
CleanTECH San Diego Showcase: Smart Grid Technologies
Ellen Pao, a partner at the Silicon Valley venture capital firm Kleiner Perkins Caufield & Byers, is scheduled to speak on the significance of smart grid technology to the nation’s electric power infrastructure. Her talk is followed by a panel discussion featuring local cleantech entrepreneurs. Online information and registration is here.
Health Care Reform and Reimbursement
The health care reforms under consideration in Washington D.C. have the potential to reshape economic incentives and require medical device companies to rethink their strategies and operations. Biocom has asked a panel of experts to discuss the proposed changes and answer questions on healthcare reform and its potential impact on health insurance reimbursement for medical … Continue reading “Health Care Reform and Reimbursement”
Health IT Convergence and New Opportunities for Entrepreneurs: A Special Program
With the federal government providing at least $19 billion to spur the adoption of electronic health record (EHR) systems, the San Diego MIT Enterprise Forum has organized a special presentation on new opportunities for entrepreneurs. Few health care organizations are building systems to effectively use the billions of gigabytes to be collected. The main event: … Continue reading “Health IT Convergence and New Opportunities for Entrepreneurs: A Special Program”
Amylin, Lilly’s Byetta Wins FDA Approval as Standalone Therapy, Without Combo Drugs
San Diego-based Amylin Pharmaceuticals (NASDAQ: [[ticker:AMLN]]) and its partner Eli Lilly got some positive news late Friday from the FDA. The agency now says the companies have clearance to market exenatide (Byetta) as a standalone therapy for diabetes, which means doctors won’t need to combine it with other common drugs, or hold it in reserve … Continue reading “Amylin, Lilly’s Byetta Wins FDA Approval as Standalone Therapy, Without Combo Drugs”
Lilly, With New Focus on Innovation (But Not Necessarily Inclusiveness), Opens San Diego Center for Biotech R&D
“Ouch.” I’m sorry to say I didn’t write about the grand opening that drug giant Eli Lilly held in La Jolla yesterday for its new biotechnology center of excellence. I didn’t know about it. I wrote last December about the difficulty of getting information from Lilly about the status of its plans to combine Applied … Continue reading “Lilly, With New Focus on Innovation (But Not Necessarily Inclusiveness), Opens San Diego Center for Biotech R&D”
Who’s Up, Who’s Down in Tech Company Earnings Land
Well, we can’t all be Amazon. While the Seattle-based e-commerce giant (NASDAQ: [[ticker:AMZN]]) raked in a $199 million profit for the third quarter of 2009—a 68 percent increase in net income over the same period last year—Microsoft (NASDAQ: [[ticker:MSFT]]) posted an 18 percent decline in its profits (still $3.57 billion, better than analysts expected). But … Continue reading “Who’s Up, Who’s Down in Tech Company Earnings Land”
Cequent Pharmaceuticals, With First Oral RNAi Drug Soon to Enter Humans, Raises $3.4M
[Update: 7:15 pm Eastern, 10/30/09] Cambridge, MA-based Cequent Pharmaceuticals, one of the many aspiring firms in the field of RNA interference drug technology, has raised $3.35 million in equity in the first tranche of a venture round that could be worth as much as $15 million, according to CEO Peter Parker. A regulatory filing released … Continue reading “Cequent Pharmaceuticals, With First Oral RNAi Drug Soon to Enter Humans, Raises $3.4M”
RunMyErrand Picks Up $1 Million from West Coast Venture Firms
RunMyErrand, the Boston-based online clearinghouse where busy people can recruit temporary helpers to complete tasks around town, doesn’t have a branch in the San Francisco Bay Area (yet). But if it did, founder and CEO Leah Busque might be using it to pick up checks from Baseline Ventures and Maples Investments this week. Baseline, in … Continue reading “RunMyErrand Picks Up $1 Million from West Coast Venture Firms”
Onehub Raises $1.3M Series A
Bellevue, WA-based Onehub announced it has raised $1.3 million in Series A financing from Bellevue-based Ignition Partners and angel investors. Onehub makes cloud-based software for collaboration and file-sharing, and was founded in 2007. Back in April, we reported that Onehub had raised $600,000 from undisclosed investors, and in September we mentioned the company was part … Continue reading “Onehub Raises $1.3M Series A”
Verdezyne Raises $3M in Venture Funding to Advance Industrial Biotechnology
Carlsbad CA-based Verdezyne, which just disclosed a $1.7 million government grant, has raised nearly $3 million of a planned $15.2 million round of venture capital, according to a regulatory filing yesterday. The company, which was previously known as CODA Genomics, is developing genetic engineering techniques and processes for producing industrial chemicals and fuels from microbes. … Continue reading “Verdezyne Raises $3M in Venture Funding to Advance Industrial Biotechnology”
Idenix Shares Drop as Novartis Walks Away From Hepatitis C Drug
Shares of Cambridge, MA-based Idenix Pharmaceuticals plummeted in early trading this morning after Novartis declined an option to further develop an Idenix drug for the liver disease hepatitis C. Idenix (NASDAQ: [[ticker:IDIX]]) dropped 14 percent to $2.15 shortly after the opening bell this morning after the announcement, and the stock was downgraded by the investment … Continue reading “Idenix Shares Drop as Novartis Walks Away From Hepatitis C Drug”
Cleantechies Schmooze With the Gov, Compete for Cash as Three Regional Finalists Go National
Money may be tight for aspiring cleantech entrepreneurs in a downturn, but they got a little cash and some precious attention for their ideas last night. Gov. Chris Gregoire showed up to mingle at the ACT Theatre in Seattle with about a dozen entrepreneurial semi-finalists who were gathered to compete at the first Clean Tech … Continue reading “Cleantechies Schmooze With the Gov, Compete for Cash as Three Regional Finalists Go National”
Spark, Bezos Back Aviary, American Well Nabs $10M, Virdante Banks $30M, & More Boston-Area-Deals News
An unusually high percentage of this week’s New England tech and life sciences deals came from companies based in Boston proper. What’s up with that? —Spark Capital of Boston led a $7 million Series B investment in Long Island, NY-based Aviary. Backed also by Bezos Expeditions, Aviary makes cloud-based software for graphic design, audio editing, … Continue reading “Spark, Bezos Back Aviary, American Well Nabs $10M, Virdante Banks $30M, & More Boston-Area-Deals News”
Under the Radar Deals: 10 New England High-Tech Financings You Haven’t Heard About
There’s a big argument over whether venture capitalists and even angel investors are doing as many early stage or small deals these days. The general sentiment is that no, they aren’t. Since we began our monthly roundup of Massachusetts venture deals back in June, however, we’ve argued that the data doesn’t support that view: virtually … Continue reading “Under the Radar Deals: 10 New England High-Tech Financings You Haven’t Heard About”
Sony, Google Point the Way Toward a More Open Future for E-Books
In a presentation at the Boston Book Festival last weekend, Jon Orwant, a Google engineer involved in the company’s Book Search project, made a memorable and, I thought, quite perceptive remark about the e-book business. “Think about the books you have at home and how you organize them,” Orwant said. “Some of you may not … Continue reading “Sony, Google Point the Way Toward a More Open Future for E-Books”
Onehub Secures $1,300,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=96ef0db2-753a-49fe-81c8-bc72f430fe1a&Preview=1 Date 10/30/2009 Company Name Onehub Mailing Address 3380 146th Pl SE Bellevue, WA 98007 Company Description Onehub is a web application that provides everything you need to easily and securely share business information and files with partners, customers, coworkers, and suppliers. Onehub is not your typical complicated collaboration software. Instead, it’s … Continue reading “Onehub Secures $1,300,000 New Funding Round”
RUNmyERRAND Secures $1,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6f0d46a4-1c82-41d1-8ba8-26958d1ebebf&Preview=1 Date 10/30/2009 Company Name RUNmyERRAND Mailing Address 102 Bartlett Street Charlestown, MA 02129 Company Description RUNmyERRAND is about solving an age old problem – there is never enough time in the day, how are we suppose to get it all done? With RUNmyERRAND we can harness the power that has always … Continue reading “RUNmyERRAND Secures $1,000,000 Series A Financing”
Verdezyne Receives $2,960,796 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=32c3a011-111e-46b0-9912-09690508d2ec&Preview=1 Date 10/30/2009 Company Name Verdezyne Mailing Address 2715 Loker Avenue Carlsbad, CA 92008 Company Description Verdezyne employs its biology expertise and proprietary advanced computational algonithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize … Continue reading “Verdezyne Receives $2,960,796 New Funding Round”
Initiate Systems Acquires Accenx Technologies for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=26c9f104-4eb3-411c-8aff-a094ec82b929&Preview=1 Date 10/30/2009 Company Name Accenx Technologies Mailing Address 6 Jenner Irvine, CA 92618 Company Description Accenx was formed in 1997 and quickly established itself as an expert integration consulting firm focused on the healthcare industry. The company attracted a number of integration experts and software developers and transitioned towards software development … Continue reading “Initiate Systems Acquires Accenx Technologies for Undisclosed Sum”
MAR Systems Receives $1,500,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ba1b8d36-1cb6-4520-84e5-51d3eea9b354&Preview=1 Date 10/30/2009 Company Name MAR Systems Mailing Address 30625 Solon Road Unit G Cleveland, OH 44139 Company Description MAR Systems provides proprietary processes for the removal of metal contaminants from water and industrial fluid waste streams through the use of recycled alumina catalysts — transforming waste alumina catalysts into a major … Continue reading “MAR Systems Receives $1,500,000 Series B Financing Round”
Box.net Secures $7,109,999 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f1d9b47b-b5b2-456b-976c-dcbed0a57393&Preview=1 Date 10/30/2009 Company Name Box.net Mailing Address 409 Sherman Ave. Palo Alto, CA 94306 Company Description Launched officially in March of 2006, Box.net currently provides secure online file storage and sharing functionality to over 500,000 registered users, serving files to millions of people across the world. Box.net’s unique platform allows personal … Continue reading “Box.net Secures $7,109,999 New Funding”
Mytrus Lands $1,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=07ce1680-a495-4d9c-9130-eac64df68514&Preview=1 Date 10/30/2009 Company Name Mytrus Mailing Address 67 Millay Place Mill Valley, CA 94941 Company Description Mytrus, Inc. conducts clinical trials for pharmaceutical customers faster, better, and cheaper. Website http://www.mytrus.com/ Transaction Type Venture Equity Transaction Amount $1,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor … Continue reading “Mytrus Lands $1,000,000 New Round”
Prolifiq Wins at OEN Venture Northwest
Beaverton, OR-based Prolifiq was named winner of the day at the annual Oregon Entrepreneurs Network (OEN) Venture Northwest investor forum in Portland, OR, today. Eleven companies, including three from the Seattle area, presented to an audience of investors and entrepreneurs. Prolifiq makes mobile marketing software that helps companies distribute sales materials to customers in the … Continue reading “Prolifiq Wins at OEN Venture Northwest”
Top Tech Events of the Fall—an Xconomy Guide
My head is exploding trying to keep up with all the tech-business events going on around Seattle these days. Here’s a quick guide to the most prominent ones on my brain, in the hopes of saving you some stress (and keeping you up to date): —Last night’s “Women in Tech” event from TechFlash was a … Continue reading “Top Tech Events of the Fall—an Xconomy Guide”
Novocell Gets $20 Million Award
San Diego’s Novocell has received a disease team award totaling $20 million from the California Institute for Regenerative Medicine (CIRM) to fund work on its cell therapy for type 2 diabetes. The team includes scientists at the University of California, San Francisco, which will receive $2.8 million. Novocell’s research involves transforming embryonic stem cells into … Continue reading “Novocell Gets $20 Million Award”
San Diego’s Eric Topol Outlines a Coming Wave of Innovation in Wireless Health
Here at Xconomy, our focus on technology innovation is usually riveted on the interface where startups get built around new inventions and discoveries. But in a presentation last night at TEDMED, Eric Topol highlighted an innovative new medical device from an industrial giant that was unveiled last week at the Web 2.0 Summit in San … Continue reading “San Diego’s Eric Topol Outlines a Coming Wave of Innovation in Wireless Health”
New York Biotech Sues Sequenom for Fraud
Xenomics, a New York-based developer of molecular diagnostic technologies, says it has filed a suit in New York state court alleging that San Diego’s Sequenom fraudulently misrepresented the status of its prenatal Down syndrome test. Xenomics alleges the fraud induced them to exclusively license valuable patent rights to Sequenom. According to a licensing agreement announced … Continue reading “New York Biotech Sues Sequenom for Fraud”
Energy Experts React to Forthcoming Cleantech Incubator from McKinstry
The smell of startup incubators is in the air. Adeo Ressi from TheFunded recently announced that his Founder Institute training program for entrepreneurs is coming to Seattle this winter. And next week, TechStars, the seed-stage investment fund with operations in Boulder, CO, and Boston, is holding its annual reunion event in Seattle amid increasing buzz … Continue reading “Energy Experts React to Forthcoming Cleantech Incubator from McKinstry”
Xconomy Hosts Investing Legend Peter Brooke: The Photo Gallery
Last Wednesday, October 21, it was our privilege at Xconomy to provide a stage for a conversation between two legends of the investing world. The guest of honor was Peter Brooke, the founder of Advent International and TA Associates and the man most widely credited with spreading the idea of venture capital and private equity … Continue reading “Xconomy Hosts Investing Legend Peter Brooke: The Photo Gallery”
iRobot Lanches Healthcare Unit
IRobot (NASDAQ:[[ticker:IRBT]]), the Bedford, MA-based maker of robots such as the Roomba for vacuuming and the PackBot for the military, revealed today that it has created a healthcare unit to focus on developing robots that help seniors live independently in their homes. Technology veteran Tod Loofbourrow is heading the new healthcare unit as its president … Continue reading “iRobot Lanches Healthcare Unit”
Singapore Backs ScanScout in $8.5M B Round
ScanScout, a Boston-based provider of in-stream online video ads, said it has completed its $8.5 million Series B round of venture capital with an investment from EDB Investments, a firm that invests on behalf of the government of Singapore. ScanScout is also establishing an office in Singapore as part its expansion into the Asian market. … Continue reading “Singapore Backs ScanScout in $8.5M B Round”
UK’s Enigma Looks to San Diego, Life Gets Sweeter for Senomyx, Arena Says Obesity Drug Is Not “Wimpy,” & More San Diego Life Sciences News
San Diego’s life sciences news picked up a bit last week amid fresh signs of the area’s growing prominence in the laboratory tools and diagnostics sectors. —Carlsbad, CA-based Helixis, a startup maker of genetic analysis technology from the Caltech labs of Nobel Laureate David Baltimore and Axel Scherer, raised $1.8 million from unidentified investors, according … Continue reading “UK’s Enigma Looks to San Diego, Life Gets Sweeter for Senomyx, Arena Says Obesity Drug Is Not “Wimpy,” & More San Diego Life Sciences News”
R.I.P. Orange Labs Cambridge (2002-2009): A Story of Opportunities Missed
[Corrected and updated, 10/28/09, 12:40 p.m.; see page 4.] Back in 2002, it must have sounded like a good idea for Orange, a fast-growing European wireless provider known more for the simplicity of its services than for their sophistication, to open an R&D center in Boston, where it could hire a troop of brainy engineers, … Continue reading “R.I.P. Orange Labs Cambridge (2002-2009): A Story of Opportunities Missed”
Excaliard, an Isis Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials
Isis Pharmaceuticals (NASDAQ: [[ticker:ISIS]]) likes to talk about how its gene-silencing technology known as antisense creates so many innovative ideas for new drugs that it can’t commercialize them all itself, so it spins a few off into what CEO Stanley Crooke calls “satellite companies.” One of the more interesting ideas orbiting around Isis in Carlsbad, … Continue reading “Excaliard, an Isis Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials”
ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft’s HealthVault Seeks Users, & More Seattle Area Life Sciences News
We had a little something for everybody on the life sciences beat this week, with news on biopharmaceuticals, devices, and healthcare software. —Seattle-based Omeros (NASDAQ: [[ticker:OMER]]) had potential to be a bellwether for the U.S. biotech sector earlier this month, as the first true biopharmaceutical company to go public since February 2008. But its stock … Continue reading “ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft’s HealthVault Seeks Users, & More Seattle Area Life Sciences News”
Virdante Pharma Lands $30M in A Round to Combat Inflammation
Virdante Pharmaceuticals is expanding development of its anti-inflammatory drugs with a second closing of what is now a $30 million Series A round of venture capital, the company’s CEO, John Ripple, said. The Cambridge, MA-based biotech startup has found potential ways to boost the anti-inflammatory effects of conventional antibody drugs and to create novel therapies … Continue reading “Virdante Pharma Lands $30M in A Round to Combat Inflammation”
Virdante Pharmaceuticals Garners $47,750,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f2093eb0-7909-4d68-9135-22c7ee4b2b04&Preview=1 Date 10/29/2009 Company Name Virdante Pharmaceuticals Mailing Address 14 Cambridge Center Bldg 1 Cambridge, MA 02142 Company Description Virdante is a privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. Website http://www.virdante.com Transaction Type Venture Equity Transaction Amount $47,750,000 Transaction Round Undisclosed Proceeds … Continue reading “Virdante Pharmaceuticals Garners $47,750,000 New Financing”